← Back to Clinical Trials
Recruiting NCT05921682

NCT05921682 Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05921682
Status Recruiting
Phase
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition Heat Stroke
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2023-05-28
Primary Completion 2025-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
observation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2023-05-28 with a primary completion date of 2025-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke. The main questions it aims to answer are: * the optimal target body temperature at 0.5 h, 2 h, and the lowest body temperature of heat stroke. * the best body temperature at the cutting point of stop cooling. * The relationship between the volume and speed of ice saline infusion and the cooling effect.

Eligibility Criteria

Inclusion Criteria: * ≥ 18 years; ② diagnosed as heat stroke; ③ Informed consent from patients or family members. Exclusion Criteria: * need immediate cardiopulmonary resuscitation; ② transferred from another hospital; ③ with severe underlying organ insufficiency; ④ pregnant women.

Contact & Investigator

Central Contact

Xiuqin Feng

✉ fengxiuqin@zju.edu.cn

📞 +8613757119151

Principal Investigator

Lan Chen

PRINCIPAL INVESTIGATOR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Frequently Asked Questions

Who can join the NCT05921682 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heat Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05921682 currently recruiting?

Yes, NCT05921682 is actively recruiting participants. Contact the research team at fengxiuqin@zju.edu.cn for enrollment information.

Where is the NCT05921682 trial being conducted?

This trial is being conducted at Yiwu, China, Dongyang, China, Hangzhou, China, Jinhua, China and 2 additional locations.

Who is sponsoring the NCT05921682 clinical trial?

NCT05921682 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is Lan Chen at Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology